Home | Welcome to Contract Pharma   
Last Updated Tuesday, October 21 2014
Print RSS Feed

Breaking News

Related Searches:
March 23, 2011
Southern Research Institute has signed a services agreement with the Biomedical Research Foundation of Northwest Louisiana to provide commercial non-invasive preclinical imaging services.  Read More »
March 23, 2011
Aptiv Solutions and Cancer Genetics, Inc. (CGI) have formed a strategic partnership to provide comprehensive solutions for the conduct of oncology clinical trials.   Read More »
March 22, 2011
Cephalon, Inc. has signed a definitive merger agreement to acquire Gemin X Pharmaceuticals, Inc., a privately-held biopharmaceutical company, for $225 million cash.  Read More »
March 22, 2011
Merck and Sanofi-Aventis have terminated their agreement to form a new animal health joint venture by combining their animal health businesses Intervet/Schering-Plough and Merial.  Read More »
March 22, 2011
Tesaro, Inc. has signed an agreement with Amgen to gain exclusive worldwide rights for the development, manufacture, commercialization of small molecule inhibitors of Anaplastic Lymphoma Kinase (ALK).  Read More »
March 22, 2011
Gerresheimer AG has acquired Vedat, a Brazilian manufacturer of plastic pharmaceutical packaging products, in an effort to strengthen its pharmaceutical packaging business in South America.  Read More »
March 22, 2011
Sales services segment revenue for the quarter was $41.4 million (+97%) and for the year was $133.3 million (+82%).  Read More »
March 21, 2011
Novartis received approval from the European Commission for Gilenya (fingolimod) 0.5 mg daily pill for the treatment of highly active relapsing-remitting multiple sclerosis (RRMS).  Read More »
March 21, 2011
Genentech’s Phase II study of its investigational Hedgehog Pathway Inhibitor, vismodegib (RG3616/GDC-0449), showed positive results in people with advanced basal cell carcinoma (aBCC), a severe form of skin cancer.   Read More »
March 21, 2011
Julia Dishman has been appointed manager of sales and marketing for BioProcess Technology Consultants.  Read More »
March 21, 2011
Almac’s Clinical Technologies business unit has formed an exclusive integrated patient management alliance with Exco InTouch that will focus on integrating the technology and processes of each company to deliver patient management, compliance, reten  Read More »
March 18, 2011
Tim McFadden has been appointed vice president and general manager of Consumer Health Softgel at Catalent Pharma Solutions, Inc. Mr. McFadden will be located at Catalent’s headquarters in Somerset, NJ. He replaces Jorge Castro, who is retiring…  Read More »
March 18, 2011
Quest Diagnostics, Inc. will acquire Celera Corp. for $671 million, providing Quest with access to genetic tests and an R&D pipeline focused on cardiovascular disease and cancer.  Read More »
March 18, 2011
Sage Bionetworks and AstraZeneca have entered a collaboration to investigate certain cancers using advanced computational models of disease genetics.   Read More »
March 18, 2011
Ambrilia has entered into an agreement granting ZBx Corp. an option to acquire exclusive worldwide rights to Ambrilia's PSP-94 reagents and related intellectual property.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On